Trends and Disparities in Mortality from Malignant Parotid Gland Tumors in the United States, 1999-2023: A Population-Based Analysis
Cancer Informatics · 2026-07 · 25
DOI: 10.1177/11769351261471527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Informatics, online erschienen am 20.07.2026. Verfasst von Qianqian Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Malignant parotid gland tumors account for less than 1% of all cancers yet represent a substantial proportion of head and neck malignancies. Long-term mortality trends and demographic disparities remain poorly defined. This study examined mortality trends and disparities across demographic and geographic subgroups in the United States.
Methods
This repeated cross-sectional study analyzed CDC WONDER death certificate data for malignant parotid gland tumors (ICD-10-CM C07) from 1999 to 2023. AAMRs were calculated using the 2000 US standard population. Joinpoint regression estimated APCs and AAPCs with 95% CIs. Mortality was stratified by age, sex, race/ethnicity, and geography.
Results
During the study period, 15,133 deaths from malignant parotid gland tumors were recorded. Annual deaths increased from 491 in 1999 to 696 in 2023, but the overall AAMR remained stable (AAPC = -0.09, 95% CI, -0.43 to 0.25). Declines were observed among females, males, adults aged 45 to 74 years, the Northeast region, Florida, and New York. Mortality increased among adults aged 85 years or older (AAPC = 1.22, 95% CI, 0.67 to 1.77). Trends for NH White and NH Black populations were stable; smaller race/ethnicity groups had limited or unstable estimates.
Conclusion
Overall mortality from malignant parotid gland tumors remained stable from 1999 to 2023. This stable national pattern masked declines in selected strata and increasing mortality among adults aged 85 years or older. Because CDC WONDER lacks clinical, treatment, socioeconomic, and tumor-specific variables, these findings should be interpreted as descriptive mortality patterns rather than causal evidence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- College of Alberta, Wenzhou Medical University, Wenzhou, China.
- Department of Information, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Pathology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Tongbin Zhang
Zitieren
APA
Xu, Q., Li, S., Liao, F., Lou, D., & Zhang, T. (2026). Trends and Disparities in Mortality from Malignant Parotid Gland Tumors in the United States, 1999-2023: A Population-Based Analysis. Cancer Informatics, 25. https://doi.org/10.1177/11769351261471527
Vancouver
Xu Q, Li S, Liao F, Lou D, Zhang T. Trends and Disparities in Mortality from Malignant Parotid Gland Tumors in the United States, 1999-2023: A Population-Based Analysis. Cancer Informatics. 2026;25. doi:10.1177/11769351261471527
BibTeX
@article{Xu2026,
author = {Xu, Qianqian and Li, Sunjun and Liao, Fangyuan and Lou, Donghao and Zhang, Tongbin},
title = {Trends and Disparities in Mortality from Malignant Parotid Gland Tumors in the United States, 1999-2023: A Population-Based Analysis},
journal = {Cancer Informatics},
year = {2026},
volume = {25},
doi = {10.1177/11769351261471527}
}
EUVIMED